Exchange: NASDAQ·Updated 12:53 PM EDT
MYGN logo

MYGN Myriad Genetics, Inc.

$3.20
$0.035
(1.08%)
Today
EarningsNov 2
Mkt Cap$308.95M
Vol313,452.00

About MYGN

Myriad Genetics, Inc. is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. It develops and commercializes molecular tests that help patients and providers uncover genetic insights. The company was founded by Walter A. Gilbert, Mark H. Skolnick, and Peter D. Meldrum in May 1991 and is headquartered in Salt Lake City, UT.
44

Bearish Sentiment

How do you feel about MYGN?

Advertisement|Remove ads.